SP
LLY icon

Saranac Partners’s Eli Lilly LLY Stock Holding History

Saranac Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$584K Buy
+487
New +$498K 0.17% 70
2025
Q1 		– Sell
-316
Closed -$244K – 83
2024
Q4 		$244K Buy
+316
New +$262K 0.13% 68

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Saranac Partners's LLY Position: Q2 2026 in Review

Saranac Partners opened a new position in Eli Lilly (LLY) in Q2 2026: 487 shares worth $584K. The stake represents 0.17% of the portfolio and ranks #70 among its holdings. This is a return to the name: Saranac Partners previously reported a position in LLY as recently as Q4 2024.

Saranac Partners first reported a position in LLY in Q4 2024 and has held it in 2 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Saranac Partners held 487 shares of Eli Lilly worth $584K as of Q2 2026.
  • Eli Lilly was a new Saranac Partners position in Q2 2026.
  • Eli Lilly made up 0.17% of Saranac Partners's portfolio in Q2 2026, its #70 holding.
  • Saranac Partners first reported a position in Eli Lilly in Q4 2024 and has held it in 2 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Saranac Partners's 13F filing for Q2 2026, filed 13 Aug 2026.